| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.003 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |